Skip to main content
. 2023 Dec 19;16(1):7. doi: 10.3390/pharmaceutics16010007

Figure 6.

Figure 6

(A) TEM micrographs and size distribution of FeAu@MIL-100(Fe) 5-shell nanostructures and FeAu@MIL-100(Fe) 10-shell nanostructures. (B) Cell viability of HSC-3 OSCC cells in the presence of FeAu NPs and FeAu@MOF nanostructures. (C) Post-hyperthermia cell viability analysis of HSC-3 OSCC cells with or without DOX-encapsulated within FeAu@MOF nanostructures. Reproduced with permission from ref. [173] (Copyright 2022 Elsevier).